ALFA Finder| Revenue growth | 26% YoY consolidated; Care Health grew 37% in GWP terms. |
|---|---|
| Margins | Care Health combined ratio at 102.6%, aiming for 100% in 2 years. |
| Order book | NBFC/HFC book size ambitions of ₹10,000-15,000 Cr with fresh capital. |
| Demand visibility | Strong structural tailwinds in affordable housing; land-grab moment in health insurance. |
| Management confidence | High in insurance; repairing mode for broking and lending segments. |
Growth
Consolidated revenue up 26%; Broking PBT grew 53% YoY; Care Health GWP grew 37% YoY.
Outlook
Ambitious goal of ₹10,000-15,000 Cr book size for lending; Care aiming for 100% combined ratio in 2 years.
Risks
RBI rejected demerger application; high competitive intensity in health insurance; transition period for lending businesses.
Last quarter's promises, checked
Delivered
- Guided Care GWP growth better than industry → delivered 37% vs 30% (= BEAT)
- Guided Care combined ratio improvement → delivered 120 bps reduction to 101.4% (= BEAT)
- Guided NBFC/Broking profitability → delivered PAT of ₹139 Cr and ₹23 Cr respectively (= BEAT)
Partly delivered
- Guided Care combined ratio near 100% → delivered 102.6% in current call (= PARTIAL)
Missed
- Guided demerger scheme implementation → delivered RBI rejection of application (= MISS)
Earnings Call Transcript filed with BSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹230.78
- Market cap
- ₹7,956 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 343.0×Sector 20.8×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Religare Enterprises Board Meeting Date
Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.
Religare Enterprises Credit Rating
Religare Enterprises disclosed that CRISIL upgraded credit ratings for its subsidiary Religare Broking's Rs. 500 Crore bank facilities. Long-term rating moved to BBB+/Stable and short-term to A2+.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Religare Enterprises Management Change
Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.
Religare Enterprises Other Announcement
Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).